The Effects of Nexium on the Side Effects Associated With a Colonoscopy Prep
NCT00225238 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2013-06-05
Summary
The purpose of this study is to ascertain if the use of Nexium for 7 days prior to taking a colon prep for a colonoscopy will decrease the side effects that are associated with the colon preparation
Conditions
Interventions
- DRUG
-
esomeprazole (PPI)
Sponsors & Collaborators
-
Thomas Jefferson University
lead OTHER
Principal Investigators
-
David Kastenberg, MD · Thomas Jefferson University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Primary Completion
- 2007-10-31
- Completion
- 2007-10-31
Countries
- United States
Study Locations
More Related Trials
-
Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome
NCT00079833 ·Status: COMPLETED ·Phase: PHASE3
-
Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv
NCT00626262 ·Status: COMPLETED ·Phase: PHASE4
-
Nexium Capsules Clinical Experience Investigation
NCT01434485 ·Status: COMPLETED
-
Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
NCT00635414 ·Status: COMPLETED ·Phase: PHASE4
-
Chest Pain Pilot Study
NCT00251901 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium Capsules Non-steroidal Anti-inflammatory Drug (NSAID) Specific Clinical Experience Investigation
NCT01562600 ·Status: COMPLETED
-
The Efficacy of Esomeprazole Premedication on Intraoperative Bleeding During Gastric ESD
NCT02730533 ·Status: COMPLETED ·Phase: NA
-
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00242736 ·Status: COMPLETED ·Phase: PHASE4
-
NEXIUM® in the Treatment of Moderate and Severe Erosive Esophagitis
NCT00206180 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
NCT00633672 ·Status: COMPLETED ·Phase: PHASE3
-
Proton Pump Inhibitor (PPI) Therapy for Newly Diagnosed Esophagitis
NCT00586963 ·Status: COMPLETED
-
A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer
NCT00251979 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers
NCT01591083 ·Status: COMPLETED ·Phase: PHASE4
-
Plasm Gastrin Concentrations in Response to Nexium Administration in Healthy Volunteers
NCT01135472 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Nexium on Transmucosal Esophageal Leak
NCT00216788 ·Status: UNKNOWN ·Phase: PHASE1
-
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
NCT00633412 ·Status: COMPLETED ·Phase: PHASE3
-
Nexium Dyspepsia/AST
NCT00251914 ·Status: COMPLETED ·Phase: PHASE3
-
Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects
NCT00230516 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Intragastric pH Profile After 5 Days Pantoprazole 40 mg iv Followed by Oral Esomeprazole 40 mg po or Oral Pantoprazole 40 mg po
NCT00206050 ·Status: COMPLETED ·Phase: PHASE4
-
PPI Test in GP Patients
NCT00318084 ·Status: COMPLETED ·Phase: PHASE4
-
Nexium Dyspepsia/AST
NCT00251992 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE.
NCT01129713 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
NCT00251030 ·Status: COMPLETED ·Phase: PHASE4
-
Food Interaction Study To Assess the Effect of Food on the Pharmacokinetics of Esomeprazole 20 mg/Acetylsalicylic Acid 81 mg
NCT01163630 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Asthmatics and Acid Reflux
NCT00628953 ·Status: COMPLETED ·Phase: PHASE2